🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide nausea management — March 2026 Page 3

Tirzepatide nausea management — March 2026

DataDave Wed, Sep 11, 2024 at 9:14 PM 30 replies 2,103 viewsPage 3 of 6
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Sep 12, 2024 at 4:00 AM#11
Dr.SurgeonPGH said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

That is correct as far as it goes, and here is where it stops going. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Correct me if the detail matters more than I have assumed.

21 19DebRD_ATL, KristenIndy, MarkLI_maint and 18 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Sep 12, 2024 at 6:17 AM#12
Dr.ObesityLA said:
True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of…

Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.

22 20HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 19 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Sep 12, 2024 at 8:34 AM#13
Dr.SurgeonPGH said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

23 21BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Sep 12, 2024 at 10:51 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

24 22FranDenver, Dr.BariatricHTX, LindaRN_retired and 21 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 12, 2024 at 1:08 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Report rather than reply if it drifts again.

Last edited: Sep 12, 2024 at 3:08 PM
25 23PurityPaulOR, MaxMetOK, MounjBrad and 22 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register